The specificity of ACPA for GPA in IIF and ELISA was found to be 97 to 99%, respectively; sensitivity depended on disease stage and was 95% in generalized active disease in a large cohort of GPA patients as compared to controls [10]. This evidence concerns the gene PRTN3 and granulomatosis with polyangiitis.